Pfizer’s Double Standard
Clayton Morris reports Pfizer has admitted in its own documents to the SEC that due to safety concerns and the efficacy deficiency of its vaccines, they are unlikely to gain regulatory approval.
Shockingly, Morris says, no matter the adverse affects of withholding such information, Pfizer is protected by the government from being sued by victims. On the other hand, investors in the company could take them to court if the info isn’t disclosed in their filing to the SEC. Talk about double standards. Here’s more with Clayton and Natali Morris.